Low-level laser (light) therapy (LLLT) in skin: Stimulating, healing, restoring

Seminars in Cutaneous Medicine and Surgery

Volumn 32, Issue 1, 2013, Pages 41-52

  Avci, Pinar ^a,b   Gupta, Asheesh ^a,b,c   Sadasivam, Magesh ^a,b,d   Vecchio, Daniela ^a,b   Pam, Zeev ^e   Pam, Nadav ^e   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^e Aripam Medical Center   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ACICLOVIR; ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; DOXYCYCLINE; POLYSPORIN; RETINOID; SALICYLIC ACID; TETRACYCLINE; VALACICLOVIR;

ACNE; ACNE VULGARIS; AGING; ARTICLE; BURN; CARBON DIOXIDE LASER; DEPIGMENTATION; HERPES SIMPLEX; HUMAN; HYPERTROPHIC SCAR; INFLAMMATION; KELOID; LIGHT EMITTING DIODE; LOW LEVEL LASER SYSTEM; LOW LEVEL LASER THERAPY; NEODYMIUM YAG LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSTIMULATION; PHOTOTHERAPY; PSORIASIS; RADIATION EXPOSURE; REGENERATION; REJUVENATION; SKIN; SKIN DEFECT; SUNBURN; VITILIGO; WOUND HEALING; CICATRIX; PROCEDURES; RADIATION RESPONSE; METHODOLOGY; REVIEW; SCAR;

CICATRIX; HUMANS; LASER THERAPY, LOW-LEVEL; REJUVENATION; SKIN; WOUND HEALING;

EID: 84891504569     PISSN: 10855629     EISSN: 15580768     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Chung H, Dai T, Sharma SK, et al. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40:516-533
2. Gupta A, Avci P, Sadasivam M, et al. Shining light on nanotechnology to help repair and regeneration. Biotechnol Adv. (in press)
3. Seaton ED, Mouser PE, Charakida A, et al. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris. Br J Dermatol. 2006;155:748-755
4. Barolet D. Light-emitting diodes (LEDs) in dermatology. Semin Cutan Med Surg. 2008;27:227-238
5. Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23:355-361
6. Greco M, Guida G, Perlino E, et al. Increase in RNA and protein synthesis by mitochondria irradiated with helium-neon laser. Biochem Biophys Res Commun. 1989;163:1428-1434
7. Karu TI, Pyatibrat LV, Kalendo GS. Photobiological modulation of cell attachment via cytochrome c oxidase. Photochem Photobiol Sci. 2004;3: 211-216
8. Oron U. Light therapy and stem cells: A therapeutic intervention of the future?. J Interv Cardiol. 2011;3:627-629
9. Lane N. Cell biology: Power games. Nature. 2006;443:901-903
10. Wong-Riley MT, Liang HL, Eells JT, et al. Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: Role of cytochrome c oxidase. J Biol Chem. 2005;280:4761-4771
11. Pastore D, Greco M, Petragallo VA, et al. Increase in -H+/e- ratio of the cytochrome c oxidase reaction in mitochondria irradiated with helium-neon laser. Biochem Mol Biol Int. 1994;34:817-826
12. Karu T, Pyatibrat L, Kalendo G. Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro. J Photochem Photobiol B. 1995;27: 219-223
13. Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B. 1999;49:1-17
14. Harris DM. Editorial comment biomolecular mechanisms of laser biostimulation. J Clin Laser Med Surg. 1991;9:277-280
15. Liu H, Colavitti R, Rovira II, et al. Redox-dependent transcriptional regulation. Circ Res. 2005;97:967-974
16. Peplow PV, Chung TY, Ryan B, et al. Laser photobiomodulation of gene expression and release of growth factors and cytokines from cells in culture: A review of human and animal studies. Photomed Laser Surg. 2011;29:285-304
17. Huang YY, Sharma SK, Carroll J, et al. Biphasic dose response in low level light therapy-An update. Dose Response. 2011;9:602-618
18. Huang YY, Chen AC, Carroll JD, et al. Biphasic dose response in low level light therapy. Dose Response. 2009;7:358-383
19. Posten W, Wrone DA, Dover JS, et al. Low-level laser therapy for wound healing: Mechanism and efficacy. Dermatol Surg. 2005;31: 334-340
20. Basford JR. Low intensity laser therapy: Still not an established clinical tool. Lasers Surg Med. 1995;16:331-342
21. AlGhamdi KM, Kumar A, Moussa NA. Low-level laser therapy: A useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci. 2012;27:237-249
22. Hode L. The importance of the coherency. Photomed Laser Surg. 2005; 23:431-434
23. Kligman LH. Photoaging. Manifestations, prevention, and treatment. Clin Geriatr Med. 1989;5:235-251
24. Takema Y, Yorimoto Y, Kawai M, et al. Age-related changes in the elastic properties and thickness of human facial skin. Br J Dermatol. 1994;131:641-648
25. Branham GH, Thomas JR. Rejuvenation of the skin surface: Chemical peel and dermabrasion. Facial Plast Surg. 1996;12:125-133
26. Airan LE, Hruza G. Current lasers in skin resurfacing. Facial Plast Surg Clin North Am. 2005;13:127-139
27. Paasch U, Haedersdal M. Laser systems for ablative fractional resurfacing. Expert Rev Med Devices. 2011;8:67-83
28. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing. An evaluation of 500 patients. Dermatol Surg. 1998;24:315-320
29. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, et al. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg. 1997;23:527-535; discussion 535-536
30. Sachdev M, Hameed S, Mysore V. Nonablative lasers and nonlaser systems in dermatology: Current status. Indian J Dermatol Venereol Leprol. 2011;77:380-388
31. Weiss RA, McDaniel DH, Geronemus RG. Review of nonablative photorejuvenation: Reversal of the aging effects of the sun and environmental damage using laser and light sources. Semin Cutan Med Surg. 2003;22:93-106
32. Hardaway CA, Ross EV. Nonablative laser skin remodeling. Dermatol Clin. 2002;20:97-111, ix
33. Lee SY, Park KH, Choi JW, et al. A prospective, randomized, placebocontrolled, double-blinded, and split-face clinical study on LED pho-totherapy for skin rejuvenation: Clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. J Photochem Photobiol B Biol. 2007;88:51-67
34. Dierickx CC, Anderson RR. Visible light treatment of photoaging. Dermatol Ther. 2005;18:191-208
35. Weiss RA, Weiss MA, Geronemus RG, et al. A novel non-thermal non-ablative full panel LED photomodulation device for reversal of photoaging: Digital microscopic and clinical results in various skin types. J Drugs Dermatol. 2004;3:605-610
36. Weiss RA, McDaniel DH, Geronemus RG, et al. Clinical experience with light-emitting diode (LED) photomodulation. Dermatol Surg. 2005;31:1199-1205
37. Weiss RA, McDaniel DH, Geronemus RG, et al. Clinical trial of a novel non-thermal LED array for reversal of photoaging: Clinical, histologic, and surface profilometric results. Lasers Surg Med. 2005;36:85-91
38. Bhat J, Birch J, Whitehurst C, et al. A single-blinded randomised controlled study to determine the efficacy of Omnilux revive facial treatment in skin rejuvenation. Lasers Med Sci. 2005;20:6-10
39. Russell BA, Kellett N, Reilly LR. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther. 2005;7:196-200
40. Barolet D, Roberge CJ, Auger FA, et al. Regulation of skin collagen metabolism in vitro using a pulsed 660 nm LED light source: Clinical correlation with a single-blinded study. J Invest Dermatol. 2009;129: 2751-2759
41. Abergel RP, Lyons RF, Castel JC, et al. Biostimulation of wound healing by lasers: Experimental approaches in animal models and in fibroblast cultures. J Dermatol Surg Oncol. 1987;13:127-133
42. Yu W, Naim JO, Lanzafame RJ. The effect of laser irradiation on the release of bFGF from 3T3 fibroblasts. Photochem Photobiol. 1994;59:167-170
43. Schindl A, Heinze G, Schindl M, et al. Systemic effects of low-intensity laser irradiation on skin microcirculation in patients with diabetic microangiopathy. Microvasc Res. 2002;64:240-246
44. Ben-Dov N, Shefer G, Irintchev A, et al. Low-energy laser irradiation affects satellite cell proliferation and differentiation in vitro. Biochim Biophys Acta. 1999;1448:372-380
45. Kucuk BB, Oral K, Selcuk NA, et al. The anti-inflammatory effect of low-level laser therapy on experimentally induced inflammation of rabbit temporomandibular joint retrodiscal tissues. J Orofac Pain. 2010;24:293-297
46. Geronemus RG, Weiss RA, Weiss MA, et al. Non-ablative LED photomodulation light activated fibroblast stimulation clinical trial. Lasers Surg Med. 2003;25:22
47. McDaniel DH, Newman J, Geronemus R, et al. Non-ablative nonthermal LED photomodulation-A multicenter clinical photoaging trial. Lasers Surg Med. 2003;15:22
48. Weiss RA, McDaniel DH, Geronemus R, et al. Non-ablative, nonthermal light emitting diode (LED) phototherapy of photoaged skin. Lasers Surg Med. 2004;16:31
49. Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39:180-188
50. Aziz-Jalali MH, Tabaie SM, Djavid GE. Comparison of red and infrared low-level laser therapy in the treatment of acne vulgaris. Indian J Dermatol. 2012;57:128-130
51. Rotunda AM, Bhupathy AR, Rohrer TE. The new age of acne therapy: Light, lasers, and radiofrequency. J Cosmet Laser Ther. 2004;6:191-200
52. Cunliffe WJ, Goulden V. Phototherapy and acne vulgaris. Br J Dermatol. 2000;142:855-856
53. Ross EV. Optical treatments for acne. Dermatol Ther. 2005;18:253-266
54. Sadick NS. Handheld LED array device in the treatment of acne vulgaris. J Drugs Dermatol. 2008;7:347-350
55. Goldberg DJ, Russell BA. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. J Cosmet Laser Ther. 2006;8:71-75
56. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973-978
57. Sinha RP, Häder DP. UV-induced DNA damage and repair: A review. Photochem Photobiol Sci. 2002;1:225-236
58. Calles C, Schneider M, Macaluso F, et al. Infrared A radiation influences the skin fibroblast transcriptome: Mechanisms and consequences. J Invest Dermatol. 2010;130:1524-1536
59. Schroeder P, Calles C, Benesova T, et al. Photoprotection beyond ultraviolet radiation-Effective sun protection has to include protection against infrared A radiation-induced skin damage. Skin Pharmacol Physiol. 2010;23:15-17
60. Kimura E, Kawano Y, Todo H, et al. Measurement of skin permeation/penetration of nanoparticles for their safety evaluation. Biol Pharm Bull. 2012;35:1476-1486
61. Barolet D, Boucher A. LED photoprevention: Reduced MED response following multiple LED exposures. Lasers Surg Med. 2008;40:106-112
62. Krutmann J, Schroeder P. Role of mitochondria in photoaging of human skin: The defective powerhouse model. J Investig Dermatol Symp Proc. 2009;14:44-49
63. Menezes S, Coulomb B, Lebreton C, et al. Non-coherent near infrared radiation protects normal human dermal fibroblasts from solar ultraviolet toxicity. J Invest Dermatol. 1998;111:629-633
64. Frank S, Oliver L, Lebreton-De Coster C, et al. Infrared radiation affects the mitochondrial pathway of apoptosis in human fibroblasts. J Invest Dermatol. 2004;123:823-831
65. Applegate LA, Scaletta C, Panizzon R, et al. Induction of the putative protective protein ferritin by infrared radiation: Implications in skin repair. Int J Mol Med. 2000;5:247-251
66. Yu HS, Wu CS, Yu CL, et al. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo. J Invest Dermatol. 2003;120:56-64
67. Yaar M, Grossman K, Eller M, et al. Evidence for nerve growth factormediated paracrine effects in human epidermis. J Cell Biol. 1991;115: 821-828
68. Zhai S, Yaar M, Doyle SM, et al. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res. 1996;224:335-343
69. de Paula Eduardo C, Bezinelli LM, de Paula Eduardo F, et al. Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: A clinical protocol with 3-year follow-up. Lasers Med Sci. 2012;27:1077-1083
70. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis. 1998;26:541-553; quiz 554-555
71. Muñoz Sanchez PJ, Capote Femenías JL, Díaz Tejeda A, et al. The effect of 670-nm low laser therapy on herpes simplex type 1. Photomed Laser Surg. 2012;30:37-40
72. Bello-Silva MS, de Freitas PM, Aranha AC, et al. Low-and highintensity lasers in the treatment of herpes simplex virus 1 infection. Photomed Laser Surg. 2010;28:135-139
73. Schindl A, Neumann R. Low-intensity laser therapy is an effective treatment for recurrent herpes simplex infection. Results from a randomized double-blind placebo-controlled study. J Invest Dermatol. 1999;113:221-223
74. Landthaler M, Haina D, Waidelich W. [Treatment of zoster, postzoster pain and herpes simplex recidivans in loco with laser light]. Fortschr Med. 1983;101:1039-1041
75. Perrin D, Jolivald JR, Triki H, et al. Effect of laser irradiation on latency of herpes simplex virus in a mouse model. Pathol Biol (Paris). 1997; 45:24-27
76. Körner R, Bahmer F, Wigand R. The effect of infrared laser rays on herpes simplex virus and the functions of human immunocompetent cells. Hautarzt. 1989;40:350-354
77. Inoue K, Nishioka J, Hukuda S. Suppressed tuberculin reaction in guinea pigs following laser irradiation. Lasers Surg Med. 1989;9:271-275
78. Inoue K, Nishioka J, Hukuda S. Altered lymphocyte proliferation by low dosage laser irradiation. Clin Exp Rheumatol. 1989;7:521-523
79. Yu W, Chi LH, Naim JO, et al. Improvement of host response to sepsis by photobiomodulation. Lasers Surg Med. 1997;21:262-268
80. Schindl L, Schindl M, Polo L, et al. Effects of low power laser-irradiation on differential blood count and body temperature in endotoxinpreimmunized rabbits. Life Sci. 1997;60:1669-1677
81. Manteifel V, Bakeeva L, Karu T. Ultrastructural changes in chondriome of human lymphocytes after irradiation with He-Ne laser: Appearance of giant mitochondria. J Photochem Photobiol B. 1997;38:25-30
82. Bolton P, Young S, Dyson M. Macrophage responsiveness to light therapy: A dose response study. Laser Ther. 1990;2:101-106
83. Funk JO, Kruse A, Kirchner H. Cytokine production after heliumneon laser irradiation in cultures of human peripheral blood mononuclear cells. J Photochem Photobiol B. 1992;16:347-355
84. Yu HS, Chang KL, Yu CL, et al. Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Invest Dermatol. 1996;107:593-596
85. Lee AY. Role of keratinocytes in the development of vitiligo. Ann Dermatol. 2012;24:115-125
86. Yu R, Huang Y, Zhang X, et al. Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo. J Cutan Med Surg. 2012;16: 230-244
87. Kitamura R, Tsukamoto K, Harada K, et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: Role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol. 2004;202:463-475
88. Lan CC, Wu CS, Chiou MH, et al. Low-energy helium-neon laser induces melanocyte proliferation via interaction with type IV collagen: Visible light as a therapeutic option for vitiligo. Br J Dermatol. 2009; 161:273-280
89. Lan CC, WuCS, Chiou MH, et al. Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: Recapitulation of vitiligo repigmentation in vitro. J Invest Dermatol. 2006;126:2119-2126
90. Mandel ASh, Dunaeva LP. Effect of laser therapy on blood levels of serotonin and dopamine scleroderma patients. Vestn Dermatol Venerol. 1982;8:13-17
91. Mandel AS, Haberman HF, Pawlowski D, et al. Non PUVA nonsurgical therapies for vitiligo. Clin Dermatol. 1997;15:907-919
92. Khullar SM, Brodin P, Barkvoll P, et al. Preliminary study of low-level laser for treatment of long-standing sensory aberrations in the inferior alveolar nerve. J Oral Maxillofac Surg. 1996;54:2-7; discussion 1997-1998
93. Anders JJ, Borke RC, Woolery SK, et al. Low power laser irradiation alters the rate of regeneration of the rat facial nerve. Lasers Surg Med. 1993;13:72-82
94. Rochkind S, Rousso M, Nissan M, et al. Systemic effects of low-power laser irradiation on the peripheral and central nervous system, cutaneous wounds, and burns. Lasers Surg Med. 1989;9:174-182
95. Mandel ASh. Skin repigmentation after laser therapy. Vestn Dermatol Venerol. 1984;9:26-29
96. Yu HS. Treatment of vitiligo vulgaris with helium-neon laser. MB Derma. 2000;35:13-18
97. Peacocke M, Yaar M, Mansur CP, et al. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A. 1988;85:5282-5286
98. Wu CS, Lan CC, Chiou MH, et al. Basic fibroblast growth factor promotes melanocyte migration via increased expression of p125(FAK) on melanocytes. Acta Derm Venereol. 2006;86:498-502
99. Morelli JG, Yohn JJ, Zekman T, et al. Melanocyte movement in vitro: Role of matrix proteins and integrin receptors. J Invest Dermatol. 1993;101:605-608
100. Hedley SJ, Wagner M, Bielby S, et al. The influence of extracellular matrix proteins on cutaneous and uveal melanocytes. Pigment Cell Res. 1997;10:54-59
101. Ma HJ, Zhu WY, Wang DG, et al. Endothelin-1 combined with extracellular matrix proteins promotes the adhesion and chemotaxis of amelanotic melanocytes from human hair follicles in vitro. Cell Biol Int. 2006;30:999-1006
102. Ideta R, Soma T, Tsunenaga M, et al. Cultured human dermal papilla cells secrete a chemotactic factor for melanocytes. J Dermatol Sci. 2002;28:48-59
103. Takano N, Kawakami T, Kawa Y, et al. Fibronectin combined with stem cell factor plays an important role in melanocyte proliferation, differentiation and migration in cultured mouse neural crest cells. Pigment Cell Res. 2002;15:192-200
104. Gibson WT, Couchman JR, Weaver AC. Fibronectin distribution during the development of fetal rat skin. J Invest Dermatol. 1983;81:480-485
105. Uitto J, Kouba D. Cytokine modulation of extracellular matrix gene expression: Relevance to fibrotic skin diseases. J Dermatol Sci. 2000; 24(Suppl 1):S60-S69
106. Wolfram D, Tzankov A, Pülzl P, et al. Hypertrophic scars and keloids- A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009;35:171-181
107. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol. 2007;46:80-88
108. Louw L. The keloid phenomenon: Progress toward a solution. Clin Anat. 2007;20:3-14
109. Uitto J. IL-6 signaling pathway in keloids: A target for pharmacologic intervention?. J Invest Dermatol. 2007;127:6-8
110. Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98-105
111. Liu W, Wang DR, Cao YL. TGF-beta: A fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther. 2004;4:123-136
112. Barolet D, Boucher A. Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: A case series. Lasers Surg Med. 2010;42:597-601
113. Hamblin MR, Demidova TN. Mechanisms of low level light therapy-An introduction. Proc SPIE. 2006;6140:61001-61012
114. Ablon G. Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: Preliminary findings. Photomed Laser Surg. 2010;28:141-146